{
    "2018-07-17": [
        [
            {
                "time": "2018-07-18",
                "original_text": "Pre-Market Earnings Report for July 18, 2018: ABT, MS, ASML, USB, NVS, MTB, NTRS, ERIC, TXT, GWW, MTG, UBSH",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Pre-Market",
                        "NVS"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Earnings Outlook For Novartis",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Outlook",
                        "Novartis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Roche's Flu Drug Meets Primary Endpoint in Phase III Study",
                "features": {
                    "keywords": [
                        "Roche",
                        "Flu Drug",
                        "Phase III",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Novartis’s Q2 2018 Estimates: Alcon",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Q2",
                        "Estimates",
                        "Alcon"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "The Swiss Stock Market Pulled Back As Heavyweights Fall",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Pulled Back",
                        "Heavyweights"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Novartis’s Q2 2018 Estimates: Sandoz",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Q2",
                        "Estimates",
                        "Sandoz"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}